CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CFO and COO sold 21,000 shares at an average $3.61 ($75,851)
- 4 Open-market sale Director sold 50,600 shares at an average $3.86 ($195,287)
- 4 Open-market sale Former 10% owner sold 50,600 shares at an average $3.86 ($195,287)
- 4 Open-market sale Former 10% owner sold 149,208 shares at an average $4.08 ($608,228)
- 4 Open-market sale Director sold 149,208 shares at an average $4.08 ($608,228)
- 4 Other disposition 10% owner disposed of 342,375 shares (other)
- 4 Other disposition Director disposed of 342,375 shares (other)
- 4 Other disposition 10% owner disposed of 53,000 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
Page 16 of 23 · 459 filings